Drug intelligence / Profile preview

total glucosides of paeony

Development stage
Phase 4
Lead developer
Ningbo Liwah Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Total glucosides of paeony** is a standardized multi-constituent botanical extract prepared from the root of *Paeonia lactiflora*. It is marketed in China as oral Pafulin capsules for rheumatoid arthritis. The extract is enriched in monoterpene glycosides, particularly paeoniflorin, and has anti-inflammatory and immunomodulatory activity. Its pharmacology is pleiotropic rather than attributable to one validated molecular target: preclinical studies associate TGP with reduced dendritic-cell activation, modulation of T-cell subsets including Th1, Th17 and regulatory T cells, and suppression of inflammatory signaling such as STAT1, STAT3 and p38 MAPK activity. It is being clinically investigated in several autoimmune and inflammatory diseases beyond rheumatoid arthritis. ([lansen.com.cn](https://www.lansen.com.cn/ch/jbzs.html?categoryId=19))

Brand names
Pafulin
Other names
TGPtotal glycosides of paeonytotal glucosides of white paeonyBaishaozonggan白芍总苷白芍总苷胶囊
02

Targets

IL1B (Interleukin-1 beta)IL-17A (Interleukin-17A)TNFA (Tumor necrosis factor alpha (soluble))EGFR (Epidermal growth factor receptor)SRC (Proto-oncogene tyrosine-protein kinase Src)IL-6 (Interleukin 6)STAT3 (Signal Transducer and Activator of Transcription 3)TLR9 (Toll-like receptor 9)

Beyond the preview

Go deeper on total glucosides of paeony.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on total glucosides of paeony.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call